[go: up one dir, main page]

AU2002211602A1 - Polymer controlled delivery of a therapeutic agent - Google Patents

Polymer controlled delivery of a therapeutic agent

Info

Publication number
AU2002211602A1
AU2002211602A1 AU2002211602A AU1160202A AU2002211602A1 AU 2002211602 A1 AU2002211602 A1 AU 2002211602A1 AU 2002211602 A AU2002211602 A AU 2002211602A AU 1160202 A AU1160202 A AU 1160202A AU 2002211602 A1 AU2002211602 A1 AU 2002211602A1
Authority
AU
Australia
Prior art keywords
therapeutic agent
controlled delivery
polymer controlled
polymer
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211602A
Inventor
Michael F. Haller
Kam W Leong
Catherine S. Levisage
Bernard A. Malavaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of AU2002211602A1 publication Critical patent/AU2002211602A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002211602A 2000-10-11 2001-10-11 Polymer controlled delivery of a therapeutic agent Abandoned AU2002211602A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23949800P 2000-10-11 2000-10-11
US23938500P 2000-10-11 2000-10-11
US60/239,498 2000-10-11
US60/239,385 2000-10-11
PCT/US2001/031688 WO2002030399A2 (en) 2000-10-11 2001-10-11 Polymer controlled delivery of a therapeutic agent

Publications (1)

Publication Number Publication Date
AU2002211602A1 true AU2002211602A1 (en) 2002-04-22

Family

ID=26932523

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211602A Abandoned AU2002211602A1 (en) 2000-10-11 2001-10-11 Polymer controlled delivery of a therapeutic agent

Country Status (3)

Country Link
US (1) US20030008015A1 (en)
AU (1) AU2002211602A1 (en)
WO (1) WO2002030399A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR098300A0 (en) 2000-10-25 2000-11-16 Sirtex Medical Limited Polymer based radionuclide containing microspheres
US20050043585A1 (en) * 2003-01-03 2005-02-24 Arindam Datta Reticulated elastomeric matrices, their manufacture and use in implantable devices
BRPI0410324A (en) 2003-05-15 2006-05-23 Biomerix Corp implantable device, elastomeric matrix production lyophilization processes having a cross-linked structure, polymerization for cross-linked elastomeric matrix preparation and cross-linked composite elastomeric implant preparation, and method for treating an orthopedic disorder
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
US20070190108A1 (en) * 2004-05-17 2007-08-16 Arindam Datta High performance reticulated elastomeric matrix preparation, properties, reinforcement, and use in surgical devices, tissue augmentation and/or tissue repair
US20060116714A1 (en) * 2004-11-26 2006-06-01 Ivan Sepetka Coupling and release devices and methods for their assembly and use
US20080281350A1 (en) * 2006-12-13 2008-11-13 Biomerix Corporation Aneurysm Occlusion Devices
EP2510946B1 (en) 2007-02-07 2015-08-05 The Regents of The University of California Conjugates of synthetic tlr agonists and uses therefor
WO2009099650A2 (en) * 2008-02-07 2009-08-13 Carson Dennis A Treatment of bladder diseases with a tlr7 activator
ES2774930T3 (en) 2012-03-06 2020-07-23 Univ Illinois Activation of procaspase 3 by combination therapy
US9763892B2 (en) 2015-06-01 2017-09-19 Autotelic Llc Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms
SG11202004384YA (en) 2017-11-17 2020-06-29 Univ Illinois Cancer therapy by degrading dual mek signaling
WO2020072774A1 (en) 2018-10-05 2020-04-09 The Board Of Trustees Of The University Of Illinois Combination therapy for the treatment of uveal melanoma
AU2021439740A1 (en) * 2021-04-07 2023-10-26 Watershed Medical Inc Formulation and method for treatment of urinary system disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2755136B1 (en) * 1996-10-25 1999-01-22 Virsol PROCESS FOR THE PREPARATION OF METHYLIDENE MALONATE NANOPARTICLES, NANOPARTICLES CONTAINING ONE OR MORE BIOLOGICALLY ACTIVE MOLECULES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2778100B1 (en) * 1998-04-29 2001-05-04 Virsol NOVEL POLY (METHYLIDENE MALONATE) MICROSPHERES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
US20030008015A1 (en) 2003-01-09
WO2002030399A2 (en) 2002-04-18
WO2002030399A3 (en) 2003-01-03

Similar Documents

Publication Publication Date Title
AU2001273341A1 (en) An implantable or insertable therapeutic agent delivery device
AU2002322719A1 (en) Delivery of therapeutic capable agents
AU2623201A (en) Controlled delivery of therapeutic agents by insertable medical devices
AU2002232618A1 (en) Tissue attachable drug delivery catheters/methods of use
AU2001279064A1 (en) Therapeutic azo-compounds for drug delivery
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
AU2001238386A1 (en) Medication delivery devices
AU2001235009A1 (en) Drug delivery apparatus
AU2001264887A1 (en) Drug delivery device
AU2002218250A1 (en) Medicament dispenser
AU2510001A (en) Medicament dispenser
AU2509901A (en) Medicament dispenser
AU2002246925A1 (en) Therapeutic delivery balloon
AU2003251563A1 (en) Implatable or insertable medical devices for controlled delivery of a therapeutic agent
AU2002246515A1 (en) Medicated tattoos
AU2001258095A1 (en) Drug delivery systems for photodynamic therapy
AU2123200A (en) Drug delivery device
AU4985600A (en) Drug delivery device
AU2002242883A1 (en) Medicament dispenser
AU2002251238A1 (en) Medicament dispenser
AU4947100A (en) Drug delivery device
AU2002223562A1 (en) Medicament dispenser
AU1514401A (en) Medicament dispenser
AU2002211602A1 (en) Polymer controlled delivery of a therapeutic agent
AU2001277171A1 (en) Catheter for target specific drug delivery